| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.3B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $2.95 | $2.19 | $2.48 | $1.96 | $3.12 | $2.53 | $2.84 | $2.77 |
| EPS (Diluted) | $2.94 | $2.19 | $2.48 | $1.96 | $3.11 | $2.53 | $2.83 | $2.75 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.6B | $29.1B | $30.7B | $32.3B | $19.7B | $17.6B | $14.6B | $13.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.8B | $0.8B |
| Total Liabilities | $23.2B | $25.8B | $27.4B | $29.2B | $17.7B | $15.7B | $12.6B | $11.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.4B | $3.3B | $3.2B | $3.1B | $2.0B | $2.0B | $2.0B | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.4B | $0.5B | $0.3B | $0.3B | $0.1B | $0.2B |
| Investing Cash Flow | $2.3B | $1.8B | $1.3B | $-0.9B | $-2.1B | $-1.9B | $-0.0B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-2.2B | $-1.8B | $-2.0B | $-1.1B | $1.9B | $2.8B | $0.1B | $0.0B |